Literature DB >> 3162174

Biodegradable sustained release formulation of the LH-RH analogue 'Zoladex' for the treatment of hormone-responsive tumours.

B J Furr, F G Hutchinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3162174

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  10 in total

Review 1.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.

Authors:  Susan M Cheer; Greg L Plosker; Dene Simpson; Antona J Wagstaff
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  [Problems and principles of hormone therapy of advanced prostate cancer].

Authors:  J E Altwein; P Faul
Journal:  Klin Wochenschr       Date:  1990-04-02

4.  Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.

Authors:  E J Thomas; J Jenkins; E A Lenton; I D Cooke
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

Review 5.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

6.  Enzalutamide induced acute generalized exanthematous pustulosis.

Authors:  Chloé Alberto; Maria Polina Konstantinou; Catherine Martinage; Eline Casassa; Emilie Tournier; Haleh Bagheri; Vincent Sibaud; Loïc Mourey; Juliette Mazereeuw-Hautier; Nicolas Meyer; Carle Paul; Cristina Bulai Livideanu
Journal:  J Dermatol Case Rep       Date:  2016-11-13

Review 7.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.

Authors:  P Chrisp; K L Goa
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

8.  Reversal of ageing changes in the thymus of rats by chemical or surgical castration.

Authors:  M D Kendall; F T Fitzpatrick; B D Greenstein; F Khoylou; B Safieh; A Hamblin
Journal:  Cell Tissue Res       Date:  1990-09       Impact factor: 5.249

Review 9.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancer.

Authors:  R N Brogden; D Faulds
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

10.  Pharmacokinetics and endocrine effects of the LHR analogue buserelin after subcutaneous implantation of a slow release preparation in prostatic cancer patients.

Authors:  J H Blom; W H Hirdes; F H Schröder; F H de Jong; D J Kwekkeboom; A J van't Veen; J Sandow; B Krauss
Journal:  Urol Res       Date:  1989
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.